Neil Harris Cohen insider trades

Open-market stock purchases and sales by Neil Harris Cohen, Director at Chemomab Therapeutics Ltd, from SEC Form 4 filings since Jul 16, 2020.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -81%.

Recent trades

DateStockTradeValue
Aug 28, 2026CMMB Chemomab Therapeutics LtdSold$2.8K
Aug 27, 2026CMMB Chemomab Therapeutics LtdSold$3.7K
Mar 16, 2026CMMB Chemomab Therapeutics LtdBought (not open market)—

Companies traded

  • CMMB Chemomab Therapeutics Ltd: 5 buys, 3 sales, last Aug 28, 2026
  • ANCN Anchiano Therapeutics Ltd: other filings, last Jul 16, 2020

Get free alerts when Neil Harris Cohen files a new trade →